{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:10:43Z","timestamp":1793970643176,"version":"4.8.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100030902","name":"Martin-Luther-Universit\u00e4t Halle-Wittenberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100030902","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>With the progression of late-onset Alzheimer disease (LOAD), there is a dysregulation and then a breakdown of the blood-brain barrier (BBB). An important pathological feature in the brains of patients is the accumulation of amyloid beta (A\u03b2) peptides. Their aggregation leads to the formation of particularly harmful A\u03b2 oligomers (A\u03b2-O). Unfortunately, our understanding of changes in the blood-brain barrier, particularly with regard to the effects of A\u03b2-O, is still very limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study investigated a LOAD-specific and induced pluripotent stem cell (hiPSC)-based in vitro model of the BBB for disease mechanisms and validated the findings in two independent laboratories. This study also investigated A\u03b2 transport across the BBB. Furthermore, obtained in vitro findings were confirmed in the cerebrospinal fluid proteome of a LOAD patient cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Control and LOAD hiPSCs exhibited comparable efficiency in forming brain capillary endothelial-like cells (BCECs). Although transendothelial electrical resistance (TEER) assessments indicated no significant differences in barrier tightness between LOAD and control BCECs, high-throughput multiplex qPCR analysis revealed subtle alterations in barrier integrity. This included changes in various barrier markers, such as mucins (MUC1, MUC20), aquaporins (AQP5, AQP10), junctional transcripts (CLDNs, TJP1, OCLN), and receptors (LRP1, INSR, LSR), which were confirmed in LOAD patients. High-content imaging and flow cytometry indicated reduced cadherin 5 (CDH5) levels in LOAD BCECs. Importantly, the results also highlighted a difference in the transport of A\u03b2-O across the BBB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This model demonstrates a LOAD-relevant phenotype with decreased A\u03b2 transport and alterations in key transcripts and could thus serve for future translational studies to rescue pathogenic phenotypes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12987-025-00753-7","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T03:04:11Z","timestamp":1769051051000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Brain capillary endothelial-like cells show altered barrier functionality and reduced transport of amyloid \u03b2 in late-onset Alzheimer disease"],"prefix":"10.1186","volume":"23","author":[{"given":"Carla","family":"Hartmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Undine","family":"Haferkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Appelt-Menzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janica","family":"Barenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Brachner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni","family":"Ehrhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Feldhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Gerhartl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hollemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda Anna Michelle","family":"Kulka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selin","family":"Leckzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Leu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel Seungsu","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel Alexander","family":"Friese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alzheimer\u2019s Disease Neuroimaging","family":"Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"Neuhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Oerter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Olzscha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Pich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Riemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Pless","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Rujescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"753_CR1","volume-title":"Health response to dementia","author":"Global Status Report on the Public","year":"2021","unstructured":"Global Status Report on the Public. Health response to dementia. 1st ed. Geneva: World Health Organization; 2021.","edition":"1"},{"key":"753_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22158208","author":"T-W Yu","year":"2021","unstructured":"Yu T-W, Lane H-Y, Lin C-H. Novel therapeutic approaches for alzheimer\u2019s disease: an updated review. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22158208.","journal-title":"Int J Mol Sci"},{"key":"753_CR3","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, et al. The Amyloid-\u03b2 pathway in alzheimer\u2019s disease. Mol Psychiatry. 2021;26:5481\u2013503. https:\/\/doi.org\/10.1038\/s41380-021-01249-0.","journal-title":"Mol Psychiatry"},{"key":"753_CR4","doi-asserted-by":"publisher","first-page":"570045","DOI":"10.3389\/fnmol.2020.570045","volume":"13","author":"A Michalicova","year":"2020","unstructured":"Michalicova A, Majerova P, Kovac A. Tau protein and its role in Blood-Brain barrier dysfunction. Front Mol Neurosci. 2020;13:570045. https:\/\/doi.org\/10.3389\/fnmol.2020.570045.","journal-title":"Front Mol Neurosci"},{"key":"753_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV. Blood-brain barrier breakdown in alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018;14:133\u201350. https:\/\/doi.org\/10.1038\/nrneurol.2017.188.","journal-title":"Nat Rev Neurol"},{"key":"753_CR6","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/s41593-021-00904-7","volume":"24","author":"S Schaeffer","year":"2021","unstructured":"Schaeffer S, Iadecola C. Revisiting the neurovascular unit. Nat Neurosci. 2021;24:1198\u2013209. https:\/\/doi.org\/10.1038\/s41593-021-00904-7.","journal-title":"Nat Neurosci"},{"key":"753_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3389\/fncel.2019.00405","volume":"13","author":"A Villabona-Rueda","year":"2019","unstructured":"Villabona-Rueda A, Erice C, Pardo CA, Stins MF. The evolving concept of the blood brain barrier (BBB): from a single static barrier to a heterogeneous and dynamic relay center. Front Cell Neurosci. 2019;13:405. https:\/\/doi.org\/10.3389\/fncel.2019.00405.","journal-title":"Front Cell Neurosci"},{"key":"753_CR8","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.3389\/fnins.2019.01436","volume":"13","author":"M Tjakra","year":"2019","unstructured":"Tjakra M, Wang Y, Vania V, Hou Z, Durkan C, Wang N, Wang G. Overview of crosstalk between multiple factor of transcytosis in blood brain barrier. Front Neurosci. 2019;13:1436. https:\/\/doi.org\/10.3389\/fnins.2019.01436.","journal-title":"Front Neurosci"},{"key":"753_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s43587-021-00043-5","volume":"1","author":"WA Banks","year":"2021","unstructured":"Banks WA, Reed MJ, Logsdon AF, Rhea EM, Erickson MA. Healthy aging and the blood-brain barrier. Nat Aging. 2021;1:243\u201354. https:\/\/doi.org\/10.1038\/s43587-021-00043-5.","journal-title":"Nat Aging"},{"key":"753_CR10","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3233\/JAD-200473","volume":"76","author":"E Solis","year":"2020","unstructured":"Solis E, Hascup KN, Hascup ER. Alzheimer\u2019s disease: the link between Amyloid-\u03b2 and neurovascular dysfunction. J Alzheimers Dis. 2020;76:1179\u201398. https:\/\/doi.org\/10.3233\/JAD-200473.","journal-title":"J Alzheimers Dis"},{"key":"753_CR11","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1161\/01.STR.0000143452.85382.d1","volume":"35","author":"R Deane","year":"2004","unstructured":"Deane R, Wu Z, Zlokovic BV. RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier. Stroke. 2004;35:2628\u201331. https:\/\/doi.org\/10.1161\/01.STR.0000143452.85382.d1.","journal-title":"Stroke"},{"key":"753_CR12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/164_2020_418","volume":"273","author":"SE Storck","year":"2022","unstructured":"Storck SE, Hartz AMS, Pietrzik CU. The Blood-Brain barrier in alzheimer\u2019s disease. Handb Exp Pharmacol. 2022;273:247\u201366. https:\/\/doi.org\/10.1007\/164_2020_418.","journal-title":"Handb Exp Pharmacol"},{"key":"753_CR13","doi-asserted-by":"publisher","first-page":"a006379","DOI":"10.1101\/cshperspect.a006379","volume":"2","author":"T Saido","year":"2012","unstructured":"Saido T, Leissring MA. Proteolytic degradation of amyloid \u03b2-protein. Cold Spring Harb Perspect Med. 2012;2:a006379. https:\/\/doi.org\/10.1101\/cshperspect.a006379.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"753_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fnagi.2014.00093","volume":"6","author":"T Kanekiyo","year":"2014","unstructured":"Kanekiyo T, Bu G. The low-density lipoprotein receptor-related protein 1 and amyloid-\u03b2 clearance in alzheimer\u2019s disease. Front Aging Neurosci. 2014;6:93. https:\/\/doi.org\/10.3389\/fnagi.2014.00093.","journal-title":"Front Aging Neurosci"},{"key":"753_CR15","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/acel.12045","volume":"12","author":"CA Hawkes","year":"2013","unstructured":"Hawkes CA, Gatherer M, Sharp MM, Dorr A, Yuen HM, Kalaria R, et al. Regional differences in the morphological and functional effects of aging on cerebral basement membranes and perivascular drainage of amyloid-\u03b2 from the mouse brain. Aging Cell. 2013;12:224\u201336. https:\/\/doi.org\/10.1111\/acel.12045.","journal-title":"Aging Cell"},{"key":"753_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22147710","author":"Y-C Wu","year":"2021","unstructured":"Wu Y-C, Sonninen T-M, Peltonen S, Koistinaho J, Lehtonen \u0160. Blood-Brain barrier and neurodegenerative Diseases-Modeling with iPSC-Derived brain cells. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22147710.","journal-title":"Int J Mol Sci"},{"key":"753_CR17","volume-title":"Disease-Specific stem cell models for toxicological screenings And drug development: in: stem cells in Toxicol. And med","year":"2016","unstructured":"Sahu SC, editor. Disease-Specific stem cell models for toxicological screenings And drug development: in: stem cells in Toxicol. And med. Newark: Wiley; 2016."},{"key":"753_CR18","doi-asserted-by":"publisher","first-page":"e122","DOI":"10.1002\/cpsc.122","volume":"55","author":"A Appelt-Menzel","year":"2020","unstructured":"Appelt-Menzel A, Oerter S, Mathew S, Haferkamp U, Hartmann C, Jung M, et al. Human iPSC-Derived Blood-Brain barrier models: valuable tools for preclinical drug discovery and development? Curr Protoc Stem Cell Biol. 2020;55:e122. https:\/\/doi.org\/10.1002\/cpsc.122.","journal-title":"Curr Protoc Stem Cell Biol"},{"key":"753_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00401-016-1662-x","volume":"133","author":"E Drummond","year":"2017","unstructured":"Drummond E, Wisniewski T. Alzheimer\u2019s disease: experimental models and reality. Acta Neuropathol. 2017;133:155\u201375. https:\/\/doi.org\/10.1007\/s00401-016-1662-x.","journal-title":"Acta Neuropathol"},{"key":"753_CR20","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3233\/JAD-190962","volume":"74","author":"EL Goldwaser","year":"2020","unstructured":"Goldwaser EL, Acharya NK, Wu H, Godsey GA, Sarkar A, DeMarshall CA, et al. Evidence that Brain-Reactive autoantibodies contribute to chronic neuronal internalization of exogenous Amyloid-\u03b21\u201342 and key cell surface proteins during alzheimer\u2019s disease pathogenesis. J Alzheimers Dis. 2020;74:345\u201361. https:\/\/doi.org\/10.3233\/JAD-190962.","journal-title":"J Alzheimers Dis"},{"key":"753_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/s0169-328x(99)00073-x","volume":"68","author":"U Beffert","year":"1999","unstructured":"Beffert U, Aumont N, Dea D, Lussier-Cacan S, Davignon J, Poirier J. Apolipoprotein E isoform-specific reduction of extracellular amyloid in neuronal cultures. Brain Res Mol Brain Res. 1999;68:181\u20135. https:\/\/doi.org\/10.1016\/s0169-328x(99)00073-x.","journal-title":"Brain Res Mol Brain Res"},{"key":"753_CR22","doi-asserted-by":"publisher","first-page":"112924","DOI":"10.1016\/j.biopha.2022.112924","volume":"149","author":"S Cetin","year":"2022","unstructured":"Cetin S, Knez D, Gobec S, Kos J, Pi\u0161lar A. Cell models for alzheimer\u2019s and parkinson\u2019s disease: at the interface of biology and drug discovery. Biomed Pharmacother. 2022;149:112924. https:\/\/doi.org\/10.1016\/j.biopha.2022.112924.","journal-title":"Biomed Pharmacother"},{"key":"753_CR23","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1254\/jphs.13248fp","volume":"124","author":"Y Nakamura","year":"2014","unstructured":"Nakamura Y, Matsuo J, Miyamoto N, Ojima A, Ando K, Kanda Y, et al. Assessment of testing methods for drug-induced repolarization delay and arrhythmias in an iPS cell-derived cardiomyocyte sheet: multi-site validation study. J Pharmacol Sci. 2014;124:494\u2013501. https:\/\/doi.org\/10.1254\/jphs.13248fp.","journal-title":"J Pharmacol Sci"},{"key":"753_CR24","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1177\/026119290503300618","volume":"33","author":"F Zucco","year":"2005","unstructured":"Zucco F, Batto A-F, Bises G, Chambaz J, Chiusolo A, Consalvo R, et al. An inter-laboratory study to evaluate the effects of medium composition on the differentiation and barrier function of Caco-2 cell lines. Altern Lab Anim. 2005;33:603\u201318. https:\/\/doi.org\/10.1177\/026119290503300618.","journal-title":"Altern Lab Anim"},{"key":"753_CR25","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.stemcr.2017.02.021","volume":"8","author":"A Appelt-Menzel","year":"2017","unstructured":"Appelt-Menzel A, Cubukova A, G\u00fcnther K, Edenhofer F, Piontek J, Krause G, et al. Establishment of a human Blood-Brain barrier Co-culture model mimicking the neurovascular unit using induced Pluri- and multipotent stem cells. Stem Cell Rep. 2017;8:894\u2013906. https:\/\/doi.org\/10.1016\/j.stemcr.2017.02.021.","journal-title":"Stem Cell Rep"},{"key":"753_CR26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12987-023-00471-y","volume":"20","author":"U Haferkamp","year":"2023","unstructured":"Haferkamp U, Hartmann C, Abid CL, Brachner A, H\u00f6chner A, Gerhartl A, et al. Human isogenic cells of the neurovascular unit exert transcriptomic cell type-specific effects on a blood-brain barrier in vitro model of late-onset alzheimer disease. Fluids Barriers CNS. 2023;20:78. https:\/\/doi.org\/10.1186\/s12987-023-00471-y.","journal-title":"Fluids Barriers CNS"},{"key":"753_CR27","doi-asserted-by":"publisher","first-page":"103072","DOI":"10.1016\/j.scr.2023.103072","volume":"69","author":"M Jung","year":"2023","unstructured":"Jung M, Hartmann C, Ehrhardt T, Peter L-M, Abid CL, Harwardt B, et al. Generation of a set of induced pluripotent stem cell lines from two alzheimer disease patients carrying APOE4 (MLUi007-J; MLUi008-A) and healthy old donors carrying APOE3 (MLUi009-A; MLUi010-B) to study APOE in aging and disease. Stem Cell Res. 2023;69:103072. https:\/\/doi.org\/10.1016\/j.scr.2023.103072.","journal-title":"Stem Cell Res"},{"key":"753_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12987-020-00179-3","volume":"17","author":"A Gerhartl","year":"2020","unstructured":"Gerhartl A, Pracser N, Vladetic A, Hendrikx S, Friedl H-P, Neuhaus W. The pivotal role of micro-environmental cells in a human blood-brain barrier in vitro model of cerebral ischemia: functional and transcriptomic analysis. Fluids Barriers CNS. 2020;17:19. https:\/\/doi.org\/10.1186\/s12987-020-00179-3.","journal-title":"Fluids Barriers CNS"},{"key":"753_CR29","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/wnl.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of alzheimer\u2019s disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on alzheimer\u2019s disease. Neurology. 1984;34:939\u201344. https:\/\/doi.org\/10.1212\/wnl.34.7.939.","journal-title":"Neurology"},{"key":"753_CR30","volume-title":"Structured clinical interview for DSM-IV axis II personality disorders (SCID-II)","year":"1997","unstructured":"First MB, Gibbon M, Spitzer RL, Williams JBW, Benjamin LS, editors. Structured clinical interview for DSM-IV axis II personality disorders (SCID-II). Washington, DC: American Psychiatric Press, Inc.; 1997."},{"key":"753_CR31","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1111\/j.1530-0277.1995.tb00983.x","volume":"19","author":"JP Rice","year":"1995","unstructured":"Rice JP, Reich T, Bucholz KK, Neuman RJ, Fishman R, Rochberg N, et al. Comparison of direct interview and family history diagnoses of alcohol dependence. Alcohol Clin Exp Res. 1995;19:1018\u201323. https:\/\/doi.org\/10.1111\/j.1530-0277.1995.tb00983.x.","journal-title":"Alcohol Clin Exp Res"},{"key":"753_CR32","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.scr.2018.10.004","volume":"33","author":"R Tandon","year":"2018","unstructured":"Tandon R, Br\u00e4ndl B, Baryshnikova N, Landshammer A, Steenpa\u00df L, Keminer O, et al. Generation of two human isogenic iPSC lines from fetal dermal fibroblasts. Stem Cell Res. 2018;33:120\u20134. https:\/\/doi.org\/10.1016\/j.scr.2018.10.004.","journal-title":"Stem Cell Res"},{"key":"753_CR33","doi-asserted-by":"publisher","first-page":"eabm5500","DOI":"10.1126\/sciadv.abm5500","volume":"8","author":"N Rothammer","year":"2022","unstructured":"Rothammer N, Woo MS, Bauer S, Binkle-Ladisch L, Di Liberto G, Egervari K, et al. G9a dictates neuronal vulnerability to inflammatory stress via transcriptional control of ferroptosis. Sci Adv. 2022;8:eabm5500. https:\/\/doi.org\/10.1126\/sciadv.abm5500.","journal-title":"Sci Adv"},{"key":"753_CR34","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201290","author":"MS Woo","year":"2021","unstructured":"Woo MS, Ufer F, Rothammer N, Di Liberto G, Binkle L, Haferkamp U, et al. Neuronal metabotropic glutamate receptor 8 protects against neurodegeneration in CNS inflammation. J Exp Med. 2021. https:\/\/doi.org\/10.1084\/jem.20201290.","journal-title":"J Exp Med"},{"key":"753_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2967\/jnumed.112.109009","volume":"54","author":"SM Landau","year":"2013","unstructured":"Landau SM, Breault C, Joshi AD, Pontecorvo M, Mathis CA, Jagust WJ, Mintun MA. Amyloid-\u03b2 imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods. J Nucl Med. 2013;54:70\u20137. https:\/\/doi.org\/10.2967\/jnumed.112.109009.","journal-title":"J Nucl Med"},{"key":"753_CR36","doi-asserted-by":"publisher","first-page":"e669","DOI":"10.1212\/WNL.0000000000200735","volume":"99","author":"J Dumurgier","year":"2022","unstructured":"Dumurgier J, Sabia S, Zetterberg H, Teunissen CE, Hanseeuw B, Orellana A, et al. A Pragmatic, Data-Driven method to determine cutoffs for CSF biomarkers of alzheimer disease based on validation against PET imaging. Neurology. 2022;99:e669\u201378. https:\/\/doi.org\/10.1212\/WNL.0000000000200735.","journal-title":"Neurology"},{"key":"753_CR37","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.neuron.2025.02.014","volume":"113","author":"M Ali","year":"2025","unstructured":"Ali M, Timsina J, Western D, Liu M, Beric A, Budde J, et al. Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the alzheimer disease continuum. Neuron. 2025;113:1363\u2013e13799. https:\/\/doi.org\/10.1016\/j.neuron.2025.02.014.","journal-title":"Neuron"},{"key":"753_CR38","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.1021\/acs.molpharmaceut.6b00818","volume":"13","author":"JL Mantle","year":"2016","unstructured":"Mantle JL, Min L, Lee KH. Minimum transendothelial electrical resistance thresholds for the study of small and large molecule drug transport in a human in vitro Blood-Brain barrier model. Mol Pharm. 2016;13:4191\u20138. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6b00818.","journal-title":"Mol Pharm"},{"key":"753_CR39","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta delta C(T)) method. Methods. 2001;25:402\u20138. https:\/\/doi.org\/10.1006\/meth.2001.1262.","journal-title":"Methods"},{"key":"753_CR40","doi-asserted-by":"publisher","unstructured":"Krieg K, Materna-Reichelt S, Naber T, Rachad F-Z, Kauven P, Weller A, et al. Cortical organoid-derived models of the melanoma brain metastatic niche enable prioritization of cancer-targeting drugs. Cell Rep Methods. 2025;101236. https:\/\/doi.org\/10.1016\/j.crmeth.2025.101236.","DOI":"10.1016\/j.crmeth.2025.101236"},{"key":"753_CR41","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1477-5956-9-48","volume":"9","author":"N Jochim","year":"2011","unstructured":"Jochim N, Gerhard R, Just I, Pich A. Impact of clostridial glucosylating toxins on the proteome of colonic cells determined by isotope-coded protein labeling and LC-MALDI. Proteome Sci. 2011;9:48. https:\/\/doi.org\/10.1186\/1477-5956-9-48.","journal-title":"Proteome Sci"},{"key":"753_CR42","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","volume":"13","author":"S Tyanova","year":"2016","unstructured":"Tyanova S, Temu T, Sinitcyn P, Carlson A, Hein MY, Geiger T, et al. The perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods. 2016;13:731\u201340. https:\/\/doi.org\/10.1038\/nmeth.3901.","journal-title":"Nat Methods"},{"key":"753_CR43","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1126\/science.1172482","volume":"324","author":"J Yu","year":"2009","unstructured":"Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, Thomson JA. Human induced pluripotent stem cells free of vector and transgene sequences. Science. 2009;324:797\u2013801. https:\/\/doi.org\/10.1126\/science.1172482.","journal-title":"Science"},{"key":"753_CR44","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.stemcr.2019.05.008","volume":"12","author":"EH Neal","year":"2019","unstructured":"Neal EH, Marinelli NA, Shi Y, McClatchey PM, Balotin KM, Gullett DR, et al. A Simplified, fully defined differentiation scheme for producing Blood-Brain barrier endothelial cells from human iPSCs. Stem Cell Rep. 2019;12:1380\u20138. https:\/\/doi.org\/10.1016\/j.stemcr.2019.05.008.","journal-title":"Stem Cell Rep"},{"key":"753_CR45","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1038\/srep04160","volume":"4","author":"ES Lippmann","year":"2014","unstructured":"Lippmann ES, Al-Ahmad A, Azarin SM, Palecek SP, Shusta EV. A retinoic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources. Sci Rep. 2014;4:4160. https:\/\/doi.org\/10.1038\/srep04160.","journal-title":"Sci Rep"},{"key":"753_CR46","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1172\/JCI10498","volume":"106","author":"M Shibata","year":"2000","unstructured":"Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, et al. Clearance of alzheimer\u2019s amyloid-ss(1\u201340) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest. 2000;106:1489\u201399. https:\/\/doi.org\/10.1172\/JCI10498.","journal-title":"J Clin Invest"},{"key":"753_CR47","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1172\/JCI36663","volume":"118","author":"R Deane","year":"2008","unstructured":"Deane R, Sagare A, Hamm K, Parisi M, Lane S, Finn MB, et al. ApoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J Clin Invest. 2008;118:4002\u201313. https:\/\/doi.org\/10.1172\/JCI36663.","journal-title":"J Clin Invest"},{"key":"753_CR48","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.it.2024.08.004","volume":"45","author":"RA Summers","year":"2024","unstructured":"Summers RA, Fagiani F, Rowitch DH, Absinta M, Reich DS. Novel human iPSC models of neuroinflammation in neurodegenerative disease and regenerative medicine. Trends Immunol. 2024;45:799\u2013813. https:\/\/doi.org\/10.1016\/j.it.2024.08.004.","journal-title":"Trends Immunol"},{"key":"753_CR49","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318:1917\u201320. https:\/\/doi.org\/10.1126\/science.1151526.","journal-title":"Science"},{"key":"753_CR50","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","volume":"186","author":"C L\u00f3pez-Ot\u00edn","year":"2023","unstructured":"L\u00f3pez-Ot\u00edn C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell. 2023;186:243\u201378. https:\/\/doi.org\/10.1016\/j.cell.2022.11.001.","journal-title":"Cell"},{"key":"753_CR51","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nbt.3749","volume":"35","author":"V Lo Sardo","year":"2017","unstructured":"Lo Sardo V, Ferguson W, Erikson GA, Topol EJ, Baldwin KK, Torkamani A. Influence of donor age on induced pluripotent stem cells. Nat Biotechnol. 2017;35:69\u201374. https:\/\/doi.org\/10.1038\/nbt.3749.","journal-title":"Nat Biotechnol"},{"key":"753_CR52","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1083\/jcb.201410131","volume":"208","author":"F Sohet","year":"2015","unstructured":"Sohet F, Lin C, Munji RN, Lee SY, Ruderisch N, Soung A, et al. LSR\/angulin-1 is a tricellular tight junction protein involved in blood-brain barrier formation. J Cell Biol. 2015;208:703\u201311. https:\/\/doi.org\/10.1083\/jcb.201410131.","journal-title":"J Cell Biol"},{"key":"753_CR53","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1471-4159.2012.07922.x","volume":"123","author":"C Stenger","year":"2012","unstructured":"Stenger C, Pin\u00e7on A, Hanse M, Royer L, Comte A, Koziel V, et al. Brain region-specific immunolocalization of the lipolysis-stimulated lipoprotein receptor (LSR) and altered cholesterol distribution in aged LSR+\/- mice. J Neurochem. 2012;123:467\u201376. https:\/\/doi.org\/10.1111\/j.1471-4159.2012.07922.x.","journal-title":"J Neurochem"},{"key":"753_CR54","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3233\/JAD-142127","volume":"45","author":"A Pin\u00e7on","year":"2015","unstructured":"Pin\u00e7on A, Thomas MH, Huguet M, Allouche A, Colin JC, Georges A, et al. Increased susceptibility of dyslipidemic LSR+\/- mice to amyloid stress is associated with changes in cortical cholesterol levels. J Alzheimers Dis. 2015;45:195\u2013204. https:\/\/doi.org\/10.3233\/JAD-142127.","journal-title":"J Alzheimers Dis"},{"key":"753_CR55","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13578-023-01127-y","volume":"13","author":"V Rudajev","year":"2023","unstructured":"Rudajev V, Novotny J. Cholesterol-dependent amyloid \u03b2 production: space for multifarious interactions between amyloid precursor protein, secretases, and cholesterol. Cell Biosci. 2023;13:171. https:\/\/doi.org\/10.1186\/s13578-023-01127-y.","journal-title":"Cell Biosci"},{"key":"753_CR56","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.2174\/1570159X16666180222164809","volume":"16","author":"W Li","year":"2018","unstructured":"Li W, Chen Z, Chin I, Chen Z, Dai H. The role of VE-cadherin in Blood-brain barrier integrity under central nervous system pathological conditions. Curr Neuropharmacol. 2018;16:1375\u201384. https:\/\/doi.org\/10.2174\/1570159X16666180222164809.","journal-title":"Curr Neuropharmacol"},{"key":"753_CR57","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1007\/s11357-023-00927-x","volume":"45","author":"KK Ting","year":"2023","unstructured":"Ting KK, Coleman P, Kim HJ, Zhao Y, Mulangala J, Cheng NC, et al. Vascular senescence and leak are features of the early breakdown of the blood-brain barrier in alzheimer\u2019s disease models. Geroscience. 2023;45:3307\u201331. https:\/\/doi.org\/10.1007\/s11357-023-00927-x.","journal-title":"Geroscience"},{"key":"753_CR58","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1002\/acn3.51685","volume":"9","author":"R Tarawneh","year":"2022","unstructured":"Tarawneh R, Kasper RS, Sanford J, Phuah C-L, Hassenstab J, Cruchaga C. Vascular endothelial-cadherin as a marker of endothelial injury in preclinical alzheimer disease. Ann Clin Transl Neurol. 2022;9:1926\u201340. https:\/\/doi.org\/10.1002\/acn3.51685.","journal-title":"Ann Clin Transl Neurol"},{"key":"753_CR59","doi-asserted-by":"crossref","unstructured":"Lee D, Cho SJ, Lim HJ, Seok J, Jo C, Jo SA, et al. Alteration of vascular endothelial cadherin in Alzheimer\u2019s disease patient and mouse model. 2018.","DOI":"10.1101\/430140"},{"key":"753_CR60","doi-asserted-by":"crossref","unstructured":"Knop JL, Burkard N, Danesh M, Dandekar T, Srivastava M, Hiermaier M, et al. Soluble VE-cadherin disrupts endothelial barrier function via VE-PTP\/RhoA signalling. 2022.","DOI":"10.1101\/2022.10.17.512494"},{"key":"753_CR61","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/cvr\/cvv144","volume":"107","author":"S Flemming","year":"2015","unstructured":"Flemming S, Burkard N, Renschler M, Vielmuth F, Meir M, Schick MA, et al. Soluble VE-cadherin is involved in endothelial barrier breakdown in systemic inflammation and sepsis. Cardiovasc Res. 2015;107:32\u201344. https:\/\/doi.org\/10.1093\/cvr\/cvv144.","journal-title":"Cardiovasc Res"},{"key":"753_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/biom12040530","author":"JL Trillo-Contreras","year":"2022","unstructured":"Trillo-Contreras JL, Ram\u00edrez-Lorca R, Villadiego J, Echevarr\u00eda M. Cellular distribution of brain Aquaporins and their contribution to cerebrospinal fluid homeostasis and hydrocephalus. Biomolecules. 2022. https:\/\/doi.org\/10.3390\/biom12040530.","journal-title":"Biomolecules"},{"key":"753_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076528","author":"K Yamada","year":"2023","unstructured":"Yamada K. Multifaceted roles of Aquaporins in the pathogenesis of alzheimer\u2019s disease. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24076528.","journal-title":"Int J Mol Sci"},{"key":"753_CR64","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1097\/NEN.0b013e3181fd252c","volume":"69","author":"P Moftakhar","year":"2010","unstructured":"Moftakhar P, Lynch MD, Pomakian JL, Vinters HV. Aquaporin expression in the brains of patients with or without cerebral amyloid angiopathy. J Neuropathol Exp Neurol. 2010;69:1201\u20139. https:\/\/doi.org\/10.1097\/NEN.0b013e3181fd252c.","journal-title":"J Neuropathol Exp Neurol"},{"key":"753_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10071645","author":"D Antequera","year":"2022","unstructured":"Antequera D, Carrero L, Cunha Alves V, Ferrer I, Hern\u00e1ndez-Gallego J, Municio C, Carro E. Differentially Aquaporin 5 expression in submandibular glands and cerebral cortex in alzheimer\u2019s disease. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10071645.","journal-title":"Biomedicines"},{"key":"753_CR66","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3389\/fphys.2020.00598","volume":"11","author":"H Chew","year":"2020","unstructured":"Chew H, Solomon VA, Fonteh AN. Involvement of lipids in alzheimer\u2019s disease pathology and potential therapies. Front Physiol. 2020;11:598. https:\/\/doi.org\/10.3389\/fphys.2020.00598.","journal-title":"Front Physiol"},{"key":"753_CR67","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2478\/v10042-010-0027-x","volume":"48","author":"H Porowska","year":"2010","unstructured":"Porowska H, Paszkiewicz-Gadek A, Wosek J, Wnuczko K, Rusak M, Szczepa\u0144ski M. Expression of MUC1 mucin in human umbilical vein endothelial cells (HUVEC). Folia Histochem Cytobiol. 2010;48:417\u201324. https:\/\/doi.org\/10.2478\/v10042-010-0027-x.","journal-title":"Folia Histochem Cytobiol"},{"key":"753_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9113672","author":"V Weber","year":"2020","unstructured":"Weber V, Olzscha H, L\u00e4ngrich T, Hartmann C, Jung M, Hofmann B, et al. Glycation increases the risk of microbial traversal through an endothelial model of the human Blood-Brain barrier after use of anesthetics. J Clin Med. 2020. https:\/\/doi.org\/10.3390\/jcm9113672.","journal-title":"J Clin Med"},{"key":"753_CR69","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/s41586-025-08589-9","volume":"639","author":"SM Shi","year":"2025","unstructured":"Shi SM, Suh RJ, Shon DJ, Garcia FJ, Buff JK, Atkins M, et al. Glycocalyx dysregulation impairs blood-brain barrier in ageing and disease. Nature. 2025;639:985\u201394. https:\/\/doi.org\/10.1038\/s41586-025-08589-9.","journal-title":"Nature"},{"key":"753_CR70","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s11095-024-03731-0","volume":"41","author":"E Kreutzer","year":"2024","unstructured":"Kreutzer E, Short JL, Nicolazzo JA. Effect of Apolipoprotein E isoforms on the abundance and function of P-glycoprotein in human brain microvascular endothelial cells. Pharm Res. 2024;41:1427\u201341. https:\/\/doi.org\/10.1007\/s11095-024-03731-0.","journal-title":"Pharm Res"},{"key":"753_CR71","doi-asserted-by":"publisher","first-page":"95","DOI":"10.14573\/altex.1607121","volume":"34","author":"D Pamies","year":"2017","unstructured":"Pamies D, Bal-Price A, Simeonov A, Tagle D, Allen D, Gerhold D, et al. Good cell culture practice for stem cells and stem-cell-derived models. Altex. 2017;34:95\u2013132. https:\/\/doi.org\/10.14573\/altex.1607121.","journal-title":"Altex"},{"key":"753_CR72","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12987-020-00235-y","volume":"18","author":"S Raut","year":"2021","unstructured":"Raut S, Patel R, Al-Ahmad AJ. Presence of a mutation in PSEN1 or PSEN2 gene is associated with an impaired brain endothelial cell phenotype in vitro. Fluids Barriers CNS. 2021;18:3. https:\/\/doi.org\/10.1186\/s12987-020-00235-y.","journal-title":"Fluids Barriers CNS"},{"key":"753_CR73","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/jnc.13122","volume":"134","author":"W Wan","year":"2015","unstructured":"Wan W, Cao L, Liu L, Zhang C, Kalionis B, Tai X, et al. A\u03b2(1\u201342) oligomer-induced leakage in an in vitro blood-brain barrier model is associated with up-regulation of RAGE and metalloproteinases, and down-regulation of tight junction scaffold proteins. J Neurochem. 2015;134:382\u201393. https:\/\/doi.org\/10.1111\/jnc.13122.","journal-title":"J Neurochem"},{"key":"753_CR74","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00401-006-0115-3","volume":"112","author":"JE Donahue","year":"2006","unstructured":"Donahue JE, Flaherty SL, Johanson CE, Duncan JA, Silverberg GD, Miller MC, et al. RAGE, LRP-1, and amyloid-beta protein in alzheimer\u2019s disease. Acta Neuropathol. 2006;112:405\u201315. https:\/\/doi.org\/10.1007\/s00401-006-0115-3.","journal-title":"Acta Neuropathol"},{"key":"753_CR75","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41591-020-0886-4","volume":"38","author":"JW Blanchard","year":"2020","unstructured":"Blanchard JW, Bula M, Davila-Velderrain J, Akay LA, Zhu L, Frank A, et al. Reconstruction of the human blood\u2013brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes. Nat Med. 2020;38:25. https:\/\/doi.org\/10.1038\/s41591-020-0886-4.","journal-title":"Nat Med"},{"key":"753_CR76","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/brain\/awr298","volume":"135","author":"DME van Assema","year":"2012","unstructured":"van Assema DME, Lubberink M, Bauer M, van der Flier WM, Schuit RC, Windhorst AD, et al. Blood-brain barrier P-glycoprotein function in alzheimer\u2019s disease. Brain. 2012;135:181\u20139. https:\/\/doi.org\/10.1093\/brain\/awr298.","journal-title":"Brain"},{"key":"753_CR77","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nn.3966","volume":"18","author":"EA Winkler","year":"2015","unstructured":"Winkler EA, Nishida Y, Sagare AP, Rege SV, Bell RD, Perlmutter D, et al. GLUT1 reductions exacerbate alzheimer\u2019s disease vasculo-neuronal dysfunction and degeneration. Nat Neurosci. 2015;18:521\u201330. https:\/\/doi.org\/10.1038\/nn.3966.","journal-title":"Nat Neurosci"},{"key":"753_CR78","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/0896-6273(93)90070-8","volume":"11","author":"GW Rebeck","year":"1993","unstructured":"Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic alzheimer\u2019s disease: allelic variation and receptor interactions. Neuron. 1993;11:575\u201380. https:\/\/doi.org\/10.1016\/0896-6273(93)90070-8.","journal-title":"Neuron"},{"key":"753_CR79","doi-asserted-by":"publisher","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","volume":"90","author":"DE Schmechel","year":"1993","unstructured":"Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of Apolipoprotein E genotype in late-onset alzheimer disease. Proc Natl Acad Sci U S A. 1993;90:9649\u201353. https:\/\/doi.org\/10.1073\/pnas.90.20.9649.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"753_CR80","doi-asserted-by":"publisher","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","volume":"3","author":"JM Castellano","year":"2011","unstructured":"Castellano JM, Kim J, Stewart FR, Jiang H, DeMattos RB, Patterson BW, et al. Human ApoE isoforms differentially regulate brain amyloid-\u03b2 peptide clearance. Sci Transl Med. 2011;3:89ra57. https:\/\/doi.org\/10.1126\/scitranslmed.3002156.","journal-title":"Sci Transl Med"},{"key":"753_CR81","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.stemcr.2020.03.011","volume":"14","author":"LE Oikari","year":"2020","unstructured":"Oikari LE, Pandit R, Stewart R, Cun\u00ed-L\u00f3pez C, Quek H, Sutharsan R, et al. Altered brain endothelial cell phenotype from a Familial alzheimer mutation and its potential implications for amyloid clearance and drug delivery. Stem Cell Rep. 2020;14:924\u201339. https:\/\/doi.org\/10.1016\/j.stemcr.2020.03.011.","journal-title":"Stem Cell Rep"},{"key":"753_CR82","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J. The amyloid hypothesis of alzheimer\u2019s disease at 25 years. EMBO Mol Med. 2016;8:595\u2013608. https:\/\/doi.org\/10.15252\/emmm.201606210.","journal-title":"EMBO Mol Med"},{"key":"753_CR83","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3233\/JAD-2010-101161","volume":"22","author":"PJ Ebenezer","year":"2010","unstructured":"Ebenezer PJ, Weidner AM, LeVine H, Markesbery WR, Murphy MP, Le Zhang, et al. Neuron specific toxicity of oligomeric amyloid-\u03b2: role for JUN-kinase and oxidative stress. J Alzheimers Dis. 2010;22:839\u201348. https:\/\/doi.org\/10.3233\/JAD-2010-101161.","journal-title":"J Alzheimers Dis"},{"key":"753_CR84","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ijbiomac.2022.01.117","volume":"200","author":"D Mrdenovic","year":"2022","unstructured":"Mrdenovic D, Pieta IS, Nowakowski R, Kutner W, Lipkowski J, Pieta P. Amyloid \u03b2 interaction with model cell membranes - What are the toxicity-defining properties of amyloid \u03b2? Int J Biol Macromol. 2022;200:520\u201331. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.01.117.","journal-title":"Int J Biol Macromol"},{"key":"753_CR85","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1172\/JCI57867","volume":"121","author":"M Krohn","year":"2011","unstructured":"Krohn M, Lange C, Hofrichter J, Scheffler K, Stenzel J, Steffen J, et al. Cerebral amyloid-\u03b2 proteostasis is regulated by the membrane transport protein ABCC1 in mice. J Clin Invest. 2011;121:3924\u201331. https:\/\/doi.org\/10.1172\/JCI57867.","journal-title":"J Clin Invest"},{"key":"753_CR86","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3233\/JAD-2012-112189","volume":"30","author":"TM Do","year":"2012","unstructured":"Do TM, Noel-Hudson M-S, Ribes S, Besengez C, Smirnova M, Cisternino S, et al. ABCG2- and ABCG4-mediated efflux of amyloid-\u03b2 peptide 1\u201340 at the mouse blood-brain barrier. J Alzheimers Dis. 2012;30:155\u201366. https:\/\/doi.org\/10.3233\/JAD-2012-112189.","journal-title":"J Alzheimers Dis"},{"key":"753_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158630","author":"A Herzine","year":"2022","unstructured":"Herzine A, Sekkat G, Kaminski S, Calcagno G, Boschi-Muller S, Safi H, et al. Lipolysis-Stimulated lipoprotein receptor acts as sensor to regulate ApoE release in astrocytes. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23158630.","journal-title":"Int J Mol Sci"},{"key":"753_CR88","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1172\/JCI81108","volume":"126","author":"SE Storck","year":"2016","unstructured":"Storck SE, Meister S, Nahrath J, Mei\u00dfner JN, Schubert N, Di Spiezio A, et al. Endothelial LRP1 transports amyloid-\u03b2(1\u201342) across the blood-brain barrier. J Clin Invest. 2016;126:123\u201336. https:\/\/doi.org\/10.1172\/JCI81108.","journal-title":"J Clin Invest"},{"key":"753_CR89","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.brainres.2008.06.124","volume":"1230","author":"MC Miller","year":"2008","unstructured":"Miller MC, Tavares R, Johanson CE, Hovanesian V, Donahue JE, Gonzalez L, et al. Hippocampal RAGE immunoreactivity in early and advanced alzheimer\u2019s disease. Brain Res. 2008;1230:273\u201380. https:\/\/doi.org\/10.1016\/j.brainres.2008.06.124.","journal-title":"Brain Res"},{"key":"753_CR90","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1194\/jlr.R075796","volume":"58","author":"M Shinohara","year":"2017","unstructured":"Shinohara M, Tachibana M, Kanekiyo T, Bu G. Role of LRP1 in the pathogenesis of alzheimer\u2019s disease: evidence from clinical and preclinical studies. J Lipid Res. 2017;58:1267\u201381. https:\/\/doi.org\/10.1194\/jlr.R075796.","journal-title":"J Lipid Res"},{"key":"753_CR91","doi-asserted-by":"publisher","first-page":"626636","DOI":"10.3389\/fnins.2021.626636","volume":"15","author":"N Kyrtata","year":"2021","unstructured":"Kyrtata N, Emsley HCA, Sparasci O, Parkes LM, Dickie BR. A systematic review of glucose transport alterations in alzheimer\u2019s disease. Front Neurosci. 2021;15:626636. https:\/\/doi.org\/10.3389\/fnins.2021.626636.","journal-title":"Front Neurosci"},{"key":"753_CR92","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/brain\/awac309","volume":"146","author":"M Leclerc","year":"2023","unstructured":"Leclerc M, Bourassa P, Tremblay C, Caron V, Sug\u00e8re C, Emond V, et al. Cerebrovascular insulin receptors are defective in alzheimer\u2019s disease. Brain. 2023;146:75\u201390. https:\/\/doi.org\/10.1093\/brain\/awac309.","journal-title":"Brain"},{"key":"753_CR93","doi-asserted-by":"publisher","first-page":"e14321","DOI":"10.1002\/alz.14321","volume":"21","author":"MW Weiner","year":"2025","unstructured":"Weiner MW, Kanoria S, Miller MJ, Aisen PS, Beckett LA, Conti C, et al. Overview of alzheimer\u2019s disease neuroimaging initiative and future clinical trials. Alzheimers Dement. 2025;21:e14321. https:\/\/doi.org\/10.1002\/alz.14321.","journal-title":"Alzheimers Dement"},{"key":"753_CR94","doi-asserted-by":"publisher","first-page":"103390","DOI":"10.1016\/j.mcn.2019.103390","volume":"99","author":"CC Gali","year":"2019","unstructured":"Gali CC, Fanaee-Danesh E, Zandl-Lang M, Albrecher NM, Tam-Amersdorfer C, Stracke A, et al. Amyloid-beta impairs insulin signaling by accelerating autophagy-lysosomal degradation of LRP-1 and IR-\u03b2 in blood-brain barrier endothelial cells in vitro and in 3XTg-AD mice. Mol Cell Neurosci. 2019;99:103390. https:\/\/doi.org\/10.1016\/j.mcn.2019.103390.","journal-title":"Mol Cell Neurosci"},{"key":"753_CR95","doi-asserted-by":"publisher","first-page":"fcac243","DOI":"10.1093\/braincomms\/fcac243","volume":"4","author":"R Molina-Fern\u00e1ndez","year":"2022","unstructured":"Molina-Fern\u00e1ndez R, Pic\u00f3n-Pag\u00e8s P, Barranco-Almohalla A, Crepin G, Herrera-Fern\u00e1ndez V, Garc\u00eda-El\u00edas A, et al. Differential regulation of insulin signalling by monomeric and oligomeric amyloid beta-peptide. Brain Commun. 2022;4:fcac243. https:\/\/doi.org\/10.1093\/braincomms\/fcac243.","journal-title":"Brain Commun"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-025-00753-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-025-00753-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-025-00753-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:56:22Z","timestamp":1781628982000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12987-025-00753-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["753"],"URL":"https:\/\/doi.org\/10.1186\/s12987-025-00753-7","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"assertion":[{"value":"6 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol for the use of hiPSCs MLUi007-J and MLUi009-A was reviewed by the Ethics Committee of the Medical Faculty of Martin Luther University (reference number: 2025\u2009\u2212\u2009143), and no legal or ethical concerns were raised.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}